Phylogenomics of <em>Mycobacterium africanum</em> reveals a new lineage and a complex evolutionary history (Publications)
Human tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). The MTBC comprises several human-adapted lineages known as M. tuberculosis sensu stricto, as well as two
Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a... (Publications)
Background: Infections with soil-transmitted helminths (STHs) may result in chronic inflammatory disorders affecting the human host. The objective of this study was to evaluate Fecal Calprotectin (FC)
Initial characterisation of commercially available ELISA tests and the immune response of the clinically correlated SARS-CoV-2 biobank... (Publications)
Background To accurately measure seroprevalance in the population, both the expected immune response as well as the assay performances have to be well characterised. Here, we describe the collection a
An interdisciplinary centre of excellence for pastoralists in the Horn of Africa (Publications)
The specific needs of nomadic pastoralist communities are often not considered in public services. This is also the case in the health sector. In Ethiopia, Swiss Development Cooperation is supporting
One Health - towards a more inclusive science (Publications)
How can we move in the direction of a modern theory of health that has the ability to face the new complex challenges of global change? The One Health concept suggests that health must be viewed as th
Optimization of benzothiazole and thiazole hydrazones as inhibitors of schistosome bcl-2a (Publications)
Limited therapeutic options are available for the treatment of human schistosomiasis caused by the parasitic Schistosoma flatworm. The B cell lymphoma-2 (BCL-2)-regulated apoptotic cell death pathway
Quest for a potent antimalarial drug lead: synthesis and evaluation of 6,7-dimethoxyquinazoline-2,4-diamines (Publications)
Quinazolines have long been known to exert varied pharmacologic activities that make them suitable for use in treating hypertension, viral infections, tumors, and malaria. Since 2014, we have synthesi
Parasite-host dynamics throughout antimalarial drug development stages complicate the translation of parasite clearance (Publications)
Ensuring continued success against malaria depends on a pipeline of new antimalarials. Antimalarial drug development utilizes pre-clinical murine and experimental human malaria infection studies to ev